IRIS
BARICICH, ALESSIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.159
NA - Nord America 1.548
SA - Sud America 520
EU - Europa 245
AF - Africa 45
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.523
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.480
SG - Singapore 1.368
BR - Brasile 441
CN - Cina 329
VN - Vietnam 211
HK - Hong Kong 59
IT - Italia 54
IN - India 46
DE - Germania 33
AR - Argentina 30
CA - Canada 25
FR - Francia 25
GB - Regno Unito 24
MX - Messico 20
BD - Bangladesh 19
PL - Polonia 18
RU - Federazione Russa 18
TR - Turchia 16
ID - Indonesia 14
ZA - Sudafrica 14
NL - Olanda 13
UZ - Uzbekistan 13
EC - Ecuador 12
ES - Italia 11
MA - Marocco 11
AT - Austria 9
IQ - Iraq 9
MY - Malesia 9
VE - Venezuela 9
CL - Cile 8
JP - Giappone 8
PY - Paraguay 8
UA - Ucraina 8
JM - Giamaica 7
PK - Pakistan 7
SE - Svezia 7
CO - Colombia 6
KR - Corea 5
NP - Nepal 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
JO - Giordania 4
KZ - Kazakistan 4
SA - Arabia Saudita 4
AU - Australia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
ET - Etiopia 3
GR - Grecia 3
KE - Kenya 3
LT - Lituania 3
SV - El Salvador 3
TN - Tunisia 3
AZ - Azerbaigian 2
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
EG - Egitto 2
FI - Finlandia 2
HN - Honduras 2
HR - Croazia 2
IL - Israele 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
QA - Qatar 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CM - Camerun 1
GE - Georgia 1
GI - Gibilterra 1
IE - Irlanda 1
IR - Iran 1
KG - Kirghizistan 1
KI - Kiribati 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
NA - Namibia 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
SI - Slovenia 1
TG - Togo 1
TH - Thailandia 1
TM - Turkmenistan 1
TW - Taiwan 1
Totale 4.523
Salva come PNG Salva come JPEG
Città #
Singapore 561
San Jose 350
Ashburn 287
The Dalles 218
Dallas 143
Shanghai 88
Beijing 85
Ho Chi Minh City 78
Hong Kong 53
Hanoi 45
Los Angeles 38
São Paulo 32
Santa Clara 31
New York 28
Milan 21
Buffalo 20
Warsaw 17
Rio de Janeiro 16
Prineville 13
Fort Worth 12
Haiphong 12
Montreal 12
Orem 12
Tashkent 11
Atlanta 10
Belo Horizonte 10
Charlotte 9
Chicago 9
Chennai 8
Mexico City 8
Tokyo 8
Biên Hòa 7
Boston 7
Council Bluffs 7
Denver 7
Fortaleza 7
Guayaquil 7
Lauterbourg 7
Mumbai 7
Stockholm 7
Amsterdam 6
Curitiba 6
Düsseldorf 6
Johannesburg 6
Manchester 6
Recife 6
Brooklyn 5
Caracas 5
Caxias do Sul 5
Hải Dương 5
London 5
Marília 5
Ninh Bình 5
Phoenix 5
Porto Alegre 5
Quito 5
San Francisco 5
Springfield 5
Amman 4
Ankara 4
Anápolis 4
Baghdad 4
Brasília 4
Campinas 4
Everett 4
Frankfurt am Main 4
Kingston 4
Maceió 4
Naples 4
Niterói 4
Nuremberg 4
Pasadena 4
Philadelphia 4
Poplar 4
Reston 4
Santiago 4
Sorocaba 4
São José dos Campos 4
Toronto 4
Vienna 4
Addis Ababa 3
Athens 3
Buenos Aires 3
Bắc Ninh 3
Campo Grande 3
Cape Town 3
Caratinga 3
Casablanca 3
Ciudad del Este 3
Da Nang 3
Delhi 3
Goiânia 3
Guarulhos 3
Hangzhou 3
Istanbul 3
Itajaí 3
Jackson 3
Kathmandu 3
Las Vegas 3
Limeira 3
Totale 2.552
Salva come PNG Salva come JPEG
Nome #
Post-stroke spasticity: follow-up and functional implications of chronic long-term treatment with botulinum toxin 92
ROLE OF EARLY BOTULINUM TOXIN TYPE A INJECTION IN THE TREATMENT OF PATIENTS WITH POSTSTROKE SPASTICITY: PRELIMINARY RESULTS OF AN OBSERVATIONAL STUDY 90
La valutazione dell’outcome nel percorso riabilitativo della protesi di ginocchio 83
Sensor based assessment of turning during instrumented Timed Up and Go Test for quantifying mobility in chronic stroke patients 79
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study 71
RIEDUCAZIONE DEL CAMMINO NEL MORBO DI PARKINSON: TRATTAMENTO ROBOTIZZATO VERSUS TRAINING SU TREADMILL. STUDIO RANDOMIZZATO CONTROLLATO 70
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 58
Anxiety, Stress and Depression in COVID-19 Survivors From an Italian Cohort of Hospitalized Patients: Results From a 1-Year Follow-Up 55
Ageing, functioning patterns and their environmental determinants in the spinal cord injury (SCI) population: A comparative analysis across eleven European countries implementing the International Spinal Cord Injury Community Survey 55
What is the impact of robotic rehabilitation on balance and gait outcomes in people with multiple sclerosis? A systematic review of randomized control trials 54
BoNT-A for Post-Stroke Spasticity: Guidance on Unmet Clinical Needs from a Delphi Panel Approach 51
Pain, disability, and quality of life in participants after concurrent onabotulinumtoxinA treatment of upper and lower limb spasticity: Observational results from the ASPIRE study 51
ADHERENCE TO ONABOTULINUMTOXINA TREATMENT IN POST-STROKE PATIENTS WITH SPASTICITY FROM THE ASPIRE STUDY 51
Adjunctive treatment and BoNT-A for post-stroke spasticity: Are we really focusing on the patient-centered goals? 51
Abobotulinumtoxina and rehabilitation vs rehabilitation alone in post-stroke spasticity: A cost-utility analysis 51
Botulinum Toxin for Pain Relief in Cancer Patients: A Systematic Review of Randomized Controlled Trials 50
Valutazione comparativa di tre diversi protocolli riabilitativi post-inoculo di tossina botulinica A sull’ipertono spastico dell’arto inferiore 50
Variations of muscle activity patterns in free weight versus flywheel resistance front squat: a pilot study 48
Adjuvant treatments associated with botulinum toxin injection for managing spasticity: An overview of the literature 48
ADHERENCE TO ONABOTULINUMTOXINA TREATMENT IN PATIENTS WITH SPASTICITY FROM THE ASPIRE STUDY 48
Incidence and predictors of venous thromboembolism in post-acute care patients. A prospective cohort study 48
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 48
Adherence to onabotulinumtoxina treatment in multiple sclerosis patients with spasticity from the aspire study 48
Balance Rehabilitation through Robot-Assisted Gait Training in Post-Stroke Patients: A Systematic Review and Meta-Analysis 48
Recovery from vegetative state of patients with a severe brain injury: a 4-year real-practice prospective cohort study 47
Clinical Characteristics that Impact OnabotulinumtoxinA Treatment Adherence in Patients with Spasticity from the ASPIRE Study 47
Capitolo "Strumenti di cura: Programma farmacologico" in: Foti C, Monticone M. "Manuale di medicina fisica e riabilitativa". EDRA, Milano, 2021 47
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 46
Ultrasonographic evaluation of botulinum toxin injection site for the medial approach to tibialis posterior muscle in chronic stroke patients with spastic equinovarus foot: An observational study 46
Clinical efficacy of botulinum toxin type A in patients with traumatic brain injury, spinal cord injury, or multiple sclerosis: An observational longitudinal study 46
A Rare Cause of Back Pain During Pregnancy and Lactation: Management and Treatment 46
A new mutation in the CAVIN1/PTRF gene in two siblings with congenital generalized lipodystrophy type 4: case reports and review of the literature 46
Differentiation among bio- and augmented- feedback in technologically assisted rehabilitation 45
Robotic gait training is not superior to conventional treadmill training in Parkinson's Disease: A single-blind randomized controlled trial 45
Buccal hemineglect: is it useful to evaluate the differences between the two halves of the oral cavity for the multidisciplinary rehabilitative management of right brain stroke survivors? A cross-sectional study 45
Accurate gait analysis in post-stroke patients using a single inertial measurement unit 45
Myostatin as a potential biomarker to monitor sarcopenia in hip fracture patients undergoing a multidisciplinary rehabilitation and nutritional treatment: a preliminary study 45
Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticity 44
Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke 43
ABOBOTULINUMTOXINA AND REHABILITATION VERSUS REHABILITATION ALONE IN POSTSTROKE SPASTICITY: AN ITALIAN COST-UTILITY ANALYSIS 43
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques 43
Low back pain related to a sacral insufficiency fracture: Role of paravertebral oxygen-ozone therapy in a paradigmatic case of nociplastic pain 43
Long-lasting consequences of Coronavirus disease 19 pneumonia: a systematic review 43
Identification of Factors that Impact Adherence to OnabotulinumtoxinA Treatment for Spasticity in Post-Stroke and Multiple Sclerosis Patients from ASPIRE 42
Evaluation of the safety profile of intra-articular treatment with Oxygen-Ozone therapy in knee arthrosis: controlled randomized study 42
Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19 42
Mid-term Psychiatric Outcomes of Patients Recovered From COVID-19 From an Italian Cohort of Hospitalized Patients 41
Heart Rate Variability modifications induced by high doses of incobotulinumtoxinA and onabotulinumtoxinA in hemiplegic chronic stroke patients: A single blind randomized controlled, crossover pilot study 41
Casting, taping or stretching after botulinum toxin type A for spastic equinus foot: a single-blind randomized trial on adult stroke patients 40
The value of adding mirror therapy for upper limb motor recovery of subacute stroke patients: a randomized controlled trial 40
Heart rate variability (hrv) modifications in adult hemiplegic patients after botulinum toxin type a (nt-201) injection 40
Role of Diagnostic Nerve Blocks in the Goal-Oriented Treatment of Spasticity with Botulinum Toxin Type A: A Case–Control Study 40
A single-blinded,randomized pilot study of botulinum toxin type A combined with non-pharmacological treatment for spastic foot 40
Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke 39
Urgent Measures for the Containment of the Coronavirus (Covid-19) Epidemic in the Neurorehabilitation/Rehabilitation Departments in the Phase of Maximum Expansion of the Epidemic 39
Administration of type a botulinum toxin after total hip replacement 39
Editorial: Long term disability in neurological disease: A rehabilitation perspective 39
Sarcopenic dysphagia: a narrative review 38
Influence of physician empathy on the outcome of botulinum toxin treatment for upper limb spasticity in patients with chronic stroke: A cohort study 38
Long-Term Spasticity Management in Post-Stroke Patients: Issues and Possible Actions-A Systematic Review with an Italian Expert Opinion 38
Confronto randomizzato, controllato in doppio cieco tra casting e taping nel trattamento riabilitativo dopo tossina botulinica A 38
The Lack of Systemic and Subclinical Side Effects of Botulinum Neurotoxin Type-A in Patients Affected by Post-Stroke Spasticity: A Longitudinal Cohort Study 38
RE: Impact of instrumental analysis of stiff knee gait on treatment appropriateness and associated costs in stroke patients 37
Triceps surae muscle characteristics in spastic hemiparetic stroke survivors treated with botulinum toxin type a: Clinical implications from ultrasonographic evaluation 36
Spasticity Treatment During COVID-19 Pandemic: Clinical Recommendations 35
Early botulinum toxin type a injection for post-stroke spasticity: A longitudinal cohort study 35
Short-wave diathermy for spastic equinus foot in chronic stroke patients: a proof-of-concept pilot study 35
Functional status and oral health in patients with amyotrophic lateral sclerosis: A cross-sectional study 35
Optimization of transdisciplinary management of elderly with femur proximal extremity fracture: A patient-tailored plan from orthopaedics to rehabilitation 35
Real-World Adherence to OnabotulinumtoxinA Treatment for Spasticity: Insights From the ASPIRE Study 35
Post-stroke spasticity as a condition: A new perspective on patient evaluation 35
Does altering inclination alter effectiveness of treadmill training for gait impairment after stroke? A randomized controlled trial 34
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 34
Is the Silfverskiöld Test a valid tool for evaluating calf muscles spastic overactivity in patients with stroke? A retrospective observational study 34
Can scoliosis lead to spinal cord ischaemia? Early diagnosis and rehabilitation: A paradigmatic case report and literature review 34
High-Intensity Exercise Training Impact on Cardiorespiratory Fitness, Gait Ability, and Balance in Stroke Survivors: A Systematic Review and Meta-Analysis 34
Robotic gait training is not superior to conventional treadmill training in parkinson disease: a single-blind randomized controlled trial 34
Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke 34
Peripheral facial nerve palsy: how effective is rehabilitation? 34
Power Doppler Ultrasound Findings before and after Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Pilot Study on Pain Reduction and Neovascularization Effect 34
IS THE OUTCOME OF DIAGNOSTIC NERVE BLOCK RELATED TO SPASTIC MUSCLE ECHO INTENSITY? A RETROSPECTIVE OBSERVATIONAL STUDY ON PATIENTS WITH SPASTIC EQUINOVARUS FOOT 34
Reasons and Determinants of BoNT-A Treatment Discontinuation in Patients Living with Spasticity: A 10-Year Retrospective Analysis 34
The Italian real-life post-stroke spasticity survey: unmet needs in the management of spasticity with botulinum toxin type A 33
High doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysis 33
People with Spinal Cord Injury in Italy 33
Management of stroke patients submitted to botulinum toxin type a therapy: A Delphi survey of an Italian expert panel of specialist injectors 32
Spinal Cord Injury as a Model of Bone-Muscle Interactions: Therapeutic Implications From in vitro and in vivo Studies 32
Is spasticity always the same? An observational study comparing the features of spastic equinus foot in patients with chronic stroke and multiple sclerosis 32
From paper to informatics: the Post Soft Care-App, an easy-to-use and fast tool to help therapists identify unmet needs in stroke patients 32
Effects of robot-assisted gait training on postural instability in parkinson's disease: A systematic review 32
Rectus femoris characteristics in post stroke spasticity: Clinical implications from ultrasonographic evaluation 32
Long-term effects of intra-articular oxygen-ozone therapy versus hyaluronic acid in older people affected by knee osteoarthritis: A randomized single-blind extension study 32
Development of a patient-centered questionnaire for post-stroke spasticity assessment: a reliability study 31
The Role of Botulinum Toxin Type-A in Spasticity: Research Trends from a Bibliometric Analysis 31
Chronic stroke: an oxymoron or a challenge for rehabilitation? 31
Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study 31
Safety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity Treatment 30
Falls, fractures and bone density in Parkinson’s disease–a cross-sectional study 30
Indicatori di qualità per la continuità delle cure in Medicina Riabilitativa 30
Post Soft Care: Italian implementation of a post-stroke checklist software for primary care and identification of unmet needs in community-dwelling patients 30
Totale 4.266
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.464
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.464
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.439 0 0 208 71 24 165 74 75 233 302 144 143
2025/20263.219 425 279 210 250 133 167 878 164 183 200 146 184
Totale 4.658